نتایج جستجو برای: disease cost

تعداد نتایج: 1842990  

Journal: :Research in social & administrative pharmacy : RSAP 2015
Puttarin Kulchaitanaroaj Barry L Carter Amber M Goedken Elizabeth A Chrischilles John M Brooks

BACKGROUND Hypertension is poorly controlled. Team-based care and changes in the process of care have been proposed to address these quality problems. However, assessing care processes is difficult because they are often confounded even in randomized behavioral studies by unmeasured confounders based on discretion of health care providers. OBJECTIVE To evaluate the effects of process measures...

Journal: :The Journal of infectious diseases 2011
Ann Levin Colleen Burgess Louis P Garrison Chris Bauch Joseph Babigumira Emily Simons Alya Dabbagh

BACKGROUND Measles remains an important cause of morbidity and mortality in children in developing countries. Due to the success of the measles mortality reduction and elimination efforts thus far, the WHO has raised the question of whether global eradication of measles is economically feasible. METHODS The cost-effectiveness of various measles mortality reduction and eradication scenarios wa...

Journal: :Cost effectiveness and resource allocation : C/E 2005
Andre JHA Ament Silvia MAA Evers

BACKGROUND: Earlier cost-effectiveness studies showed the cost-effectiveness ratios for pneumococcal vaccination in preventing cases of Bacteremic Pneumococcal Disease (BPD) alone to vary between 11,000 and 33,000 per quality-adjusted life year. If vaccination is also assumed to be effective in preventing cases of Non Bacteremic Pneumococcal Disease (NBPD) (at the same level of effectiveness), ...

Journal: :Cost Effectiveness and Resource Allocation 2006
Sripen Tantivess Gill Walt

BACKGROUND Much emphasis is put on providing evidence to assist policymakers in priority setting and investment decisions. Assessing the cost-effectiveness of interventions is one technique used by policymakers in their decisions around the allocation of scarce resources. However, even where such evidence is available, other considerations may also be taken into account, and even over-ride tech...

2016
Kevin A. Matthews James Holt Anne H. Gaglioti Kim A. Lochner Carla Shoff Lisa C. McGuire Kurt J. Greenlund

The prevalence of Medicare beneficiaries aged 65 years or older with 6 or more concurrent chronic conditions (MCC6+) varies geographically (1). Preventing chronic disease costs less than treating it. Chronic diseases that are well managed progress slower than those that are untreated (2). Thus, understanding how Medicare spending is distributed across the United States among older adults with t...

Journal: :Journal of neurology, neurosurgery, and psychiatry 2003
R L Stowe K Wheatley C E Clarke N J Ives R K Hills A C Williams J P Daniels R Gray

There has been a striking resurgence of interest in surgery for Parkinson's disease (PD) with new targets identified and new procedures developed. This systematic review identified over 500 studies of surgery for PD published since 1990, including over 10 000 patients. However, the authors were unable to assess the value of PD surgery reliably because only seven randomised trials were identifie...

Journal: :Bulletin of the World Health Organization 2008
Dan Chisholm Oye Gureje Sandra Saldivia Marcelo Villalón Calderón Rajitha Wickremasinghe Nalaka Mendis Jose-Luis Ayuso-Mateos Shekhar Saxena

OBJECTIVE Schizophrenia is a highly disabling disease and is costly to treat. We set out to establish what are the most cost-effective interventions applicable to developing regions and countries. METHODS Analysis was undertaken at the level of three WHO subregions spanning the Americas, Africa and South-East Asia, and subsequently in three member states (Chile, Nigeria and Sri Lanka). A stat...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2015
M Blankenburg R Pelkey H J Folse

 Limitations and uncertainties of the model findings are around (1) the correlation between albuminuria and outcomes; this correlation has been shown in retrospect but not in prospective studies; (2) outcome predictors, due to the absence of phase 3 data on finerenone‟s clinical effectiveness to change clinical outcomes; (3) availability of data for progression to macroalbuminuria, due to low ...

2018
Martina Lundqvist Jenny Alwin Martin Henriksson Magnus Husberg Per Carlsson Anne W. Ekdahl

BACKGROUND Older people with multi-morbidity are increasingly challenging for today's healthcare, and novel, cost-effective healthcare solutions are needed. The aim of this study was to assess the cost-effectiveness of comprehensive geriatric assessment (CGA) at an ambulatory geriatric unit for people ≥75 years with multi-morbidity. METHOD The primary outcome was the incremental cost-effectiv...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید